Korean J Hematol.  2002 Aug;37(3):191-199.

Cell Cycle Analysis by Ki-67 Monoclonal Antibody in Acute Myelogenous Leukemia

Affiliations
  • 1Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea. bkkim@snu.ac.kr
  • 2Cancer Research Center, Seoul National University College of Medicine, Seoul, Korea.
  • 3Department of Internal Medicine, Dankook University Medical College, Chunan, Korea.

Abstract

BACKGROUND: Flow cytometric measurement of DNA can reveal G0/G1, S, G2/M phases of cell cycle, and BrdU labeling can determine the percentage of cells in active DNA synthesis. A monoclonal antibody (MoAb), Ki-67, recognizes a protein that is present only in the nucleus of cycling cells but absent in resting cells. We analyzed whether the resting and the proliferating fraction could be differentiated by double staining with Ki-67 MoAb and propidium iodide (PI), and observed the effects of GM-CSF on cell cycle in acute myelogenous leukemia (AML) cells by Ki-67 MoAb.
METHODS
Blast cells were prepared from 9 AML patients. The cells were incubated for 48 hours with or without GM-CSF. Cells were stained with BrdU/PI and Ki-67/PI. Cell cycle was analyzed by flow cytometry.
RESULTS
The average fraction of G0/G1, S, and G2/M phases was 84.6%, 10.9%, and 4.5 % by BrdU/PI and 87.8%, 8.6%, and 3.7% by Ki-67/PI, respectively. Ki-67/PI staining dis-criminated between G0 and G1 phases and the average was 71.5% and 16.3%, respectively. In cells incubated with GM-CSF, BrdU/ PI method showed that the average S phase fraction (SPF) significantly increased from 10.9 to 16.2% (P=0.01) and the fraction of G0/G1 phase decreased from 84.6% to 78.4% (P= .02). Ki-67/PI method showed that the median SPF significantly increased from 8.6% to 13.7% (P=0.05) and G0 fraction decreased from 71.5% to 58.1% (P=0.02) but G1 fraction increased from 16.3% to 22.3% (P=0.01).
CONCLUSION
Cell cycle analysis by Ki-67 MoAb and PI in AML is rapid and simple. It is especially useful to determine the growth fraction and G0 fraction compared to BrdU/PI staining.

Keyword

Acute myelogenous leukemia; Cell cycle; Ki-67 antigen; G0 phase; Granulocyte-macrophage colony-stimulating factor

MeSH Terms

Bromodeoxyuridine
Cell Cycle*
DNA
Flow Cytometry
G0 Phase
G1 Phase
Granulocyte-Macrophage Colony-Stimulating Factor
Humans
Ki-67 Antigen
Leukemia, Myeloid, Acute*
Propidium
S Phase
Bromodeoxyuridine
DNA
Granulocyte-Macrophage Colony-Stimulating Factor
Ki-67 Antigen
Propidium
Full Text Links
  • KJH
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr